Changes in Body Composition and Cardiometabolic Health After Detraining in Older Men with Osteosarcopenia: 6-Month Follow-Up of the Randomized Controlled Franconian Osteopenia and Sarcopenia Trial (FrOST) Study.


Journal

Clinical interventions in aging
ISSN: 1178-1998
Titre abrégé: Clin Interv Aging
Pays: New Zealand
ID NLM: 101273480

Informations de publication

Date de publication:
2021
Historique:
received: 31 12 2020
accepted: 20 02 2021
entrez: 15 4 2021
pubmed: 16 4 2021
medline: 27 4 2021
Statut: epublish

Résumé

Temporary cessation of exercise but maintenance of habitual physical activity might be a frequent situation in older people's lives. Particularly the COVID-19 induced lockdown of exercise training facilities with individual outdoor activities still being allowed might be a blueprint for this potentially harmful scenario. Thus, the aim of the present study was to determine the effects of 6 months of detraining after 18 months of high-intensity resistance exercise (HIT-RT) on body composition and cardiometabolic outcomes in predominately obese older men with osteosarcopenia. Community-dwelling predominately obese men 72-91 years old with low muscle and bone mass (n=43) were randomly assigned to an 18-month HIT-RT (EG: n=21) or a non-training control group (CG, n=22). After the intervention, participants of the EG discontinued HIT-RT for 6 months, but increased their habitual physical activity. Study outcomes were group differences in detraining changes ("effects") for lean body mass (LBM), total and abdominal body fat rate (determined by dual-energy x-ray absorptiometry) and the Metabolic Syndrome Z-Score (MetSZ). We applied an intention-to-treat analysis with multiple imputation to analyze the data. After the 18-month HIT-RT, we observed significant positive training effects for LBM, total and abdominal body fat rate and the MetSZ (all p<0.001). Abrupt cessation of HIT-RT for 6 months resulted in significantly higher unfavorable changes in the HIT-RT compared with the CG for LBM (p=0.001), total body fat (p=0.003) and the MetSZ (p=0.003), apart from abdominal body fat (p=0.059). However, significant overall effects were still present after 24 months for LBM and body fat indices but not for the MetSZ. The present study clearly indicates the unfavorable effects of 6 months of detraining after HIT-RT. Correspondingly, exercise protocols particularly for older people should focus on continuous exercise with short regeneration periods rather than on intermitted protocols with pronounced training breaks.

Identifiants

pubmed: 33854307
doi: 10.2147/CIA.S299867
pii: 299867
pmc: PMC8039436
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

571-582

Informations de copyright

© 2021 Kemmler et al.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest in this work.

Références

Clin Physiol Funct Imaging. 2009 Jul;29(4):316-9
pubmed: 19302225
World Health Organ Tech Rep Ser. 1994;843:1-129
pubmed: 7941614
J Cardiopulm Rehabil. 2003 May-Jun;23(3):193-200
pubmed: 12782903
J Musculoskelet Neuronal Interact. 2004 Sep;4(3):325-34
pubmed: 15615501
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
Aging Clin Exp Res. 2019 Jan;31(1):31-39
pubmed: 29777475
Br J Sports Med. 2005 Oct;39(10):776-80
pubmed: 16183776
Eur J Clin Nutr. 2017 May;71(5):638-645
pubmed: 28120855
Br J Nutr. 2015 Jan 14;113(1):25-34
pubmed: 25234223
Br J Sports Med. 2002 Oct;36(5):340-4
pubmed: 12351331
Nutrients. 2020 Aug 05;12(8):
pubmed: 32764397
J Nutr. 2015 Nov;145(11):2520-6
pubmed: 26400966
Eur J Appl Physiol. 2010 Jun;109(3):429-35
pubmed: 20140683
J Musculoskelet Neuronal Interact. 2008 Oct-Dec;8(4):363-74
pubmed: 19147974
Proc Nutr Soc. 2016 Aug;75(3):328-41
pubmed: 27150497
Exp Gerontol. 2019 Jul 1;121:71-78
pubmed: 30978433
PLoS One. 2010 Dec 29;5(12):e15941
pubmed: 21209965
J Aging Phys Act. 2015 Oct;23(4):496-512
pubmed: 25415933
Z Gerontol Geriatr. 2008 Jun;41(3):168-76
pubmed: 18446302
Eur J Appl Physiol. 2000 Sep;83(1):51-62
pubmed: 11072774
Clin Interv Aging. 2019 Dec 16;14:2173-2186
pubmed: 31908428
J Gerontol A Biol Sci Med Sci. 2008 Jul;63(7):751-8
pubmed: 18693231
Bone. 2021 Jan;142:115772
pubmed: 33249320
Aging Clin Exp Res. 2019 Apr;31(4):503-510
pubmed: 29959666
PLoS One. 2014 Sep 30;9(9):e109141
pubmed: 25268791
Muscle Nerve. 2017 Sep;56(3):368-374
pubmed: 28044366
J Bone Miner Res. 2020 Sep;35(9):1634-1644
pubmed: 32270891
Int J Environ Res Public Health. 2019 Oct 13;16(20):
pubmed: 31614946
J Am Med Dir Assoc. 2013 Jan;14(1):10-7
pubmed: 22980996
Res Sports Med. 2016 Jul-Sep;24(3):171-84
pubmed: 27258806
Am J Epidemiol. 1998 Apr 15;147(8):755-63
pubmed: 9554417
Int J Epidemiol. 2017 Apr 1;46(2):746-755
pubmed: 28025257
J Am Med Dir Assoc. 2013 Aug;14(8):542-59
pubmed: 23867520
BMC Geriatr. 2012 Nov 07;12:68
pubmed: 23134737
Appl Physiol Nutr Metab. 2016 Oct;41(10):1018-1025
pubmed: 27636349
Front Physiol. 2020 Aug 27;11:1014
pubmed: 32973550
J Geriatr Phys Ther. 2009;32(3):117-24
pubmed: 20128336
Ann N Y Acad Sci. 2000 May;904:437-48
pubmed: 10865787
Clin Interv Aging. 2014 Jan 20;9:219-25
pubmed: 24477221
Age Ageing. 2010 Jul;39(4):412-23
pubmed: 20392703
BMJ Open Sport Exerc Med. 2020 Dec 24;6(1):e000846
pubmed: 33408874
J Strength Cond Res. 2012 Apr;26(4):1122-9
pubmed: 22126975
J Am Med Dir Assoc. 2015 Sep 1;16(9):740-7
pubmed: 26170041
Gerontology. 2009;55(2):217-23
pubmed: 19060453
J Appl Physiol (1985). 2007 Aug;103(2):432-42
pubmed: 17395756
J Strength Cond Res. 2016 Jan;30(1):267-75
pubmed: 26049792
Med Sci Sports Exerc. 2011 Jul;43(7):1177-87
pubmed: 21131862
Diabet Med. 2006 May;23(5):469-80
pubmed: 16681555
J Nutr. 2011 Aug;141(8):1489-94
pubmed: 21677076
Nutr Res. 2014 Oct;34(10):856-61
pubmed: 25277886
J Gerontol A Biol Sci Med Sci. 2000 Mar;55(3):B152-7; discussion B158-9
pubmed: 10795719
Br J Sports Med. 2005 Aug;39(8):561-4
pubmed: 16046344
Int J Environ Res Public Health. 2018 Oct 19;15(10):
pubmed: 30347735
J Nutr Health Aging. 2015 Apr;19(4):437-46
pubmed: 25809808

Auteurs

Wolfgang Kemmler (W)

Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, 91053, Germany.

Daniel Schoene (D)

Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, 91053, Germany.

Matthias Kohl (M)

Faculty Medical and Life Sciences, University of Furtwangen, Villingen-Schwenningen, 78054, Germany.

Simon von Stengel (S)

Institute of Medical Physics, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, 91053, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH